The Generic Drug Trilemma by Daniel J. Hemel, Lisa Larrimore Ouellette – SSRN Papers
New York University School of Law … Stanford Law School … But for drugs in the “patent afterlife”—the period after patent protection and other …
In: PATENT NEWS
New York University School of Law … Stanford Law School … But for drugs in the “patent afterlife”—the period after patent protection and other …
In: PATENT NEWS
Created by patent-holding inventors, patent–law specialists and experts in social and economic equity, inclusion and diversity, the multimedia TIPA …
In: PATENT NEWS
The IAM Patent 1000 publication acknowledges individual and firm greatness in all the significant aspects of patent law and practice.
In: PATENT NEWS
Providing legal and business strategy for Intellectual Property. · Supporting the AGC for litigation on all intellectual property litigation, …
In: PATENT NEWS
An opinion denying Apple Inc.’s motion to dismiss was issued Wednesday in a dispute brought by plaintiff R.N Nehushtan Trust Ltd. (RNN Trust) over …
In: PATENT NEWS
The Future of Patents for Patients: USPTO Temporarily Extends Cancer Immunotherapy Pilot Program (Patents for Patients) and Requests Public Input On Next Steps JD Supra
In: PATENT NEWS
CNIPA Releases Additional Guidance For Patent Law Enforcement The National Law Review
In: PATENT NEWS
Patent Office’s Suspension of Attorney Upheld by Federal Circuit Bloomberg Law
In: PATENT NEWS
Panasonic lawsuits say Broadcom violated computer tech patents Reuters
In: PATENT NEWS
Patent Filings Roundup: Suits Explode at End of Q2; Fortress 4G LTE Multi-District Litigation Against Auto Industry Goes to Michigan; Rare Derivation Denial IPWatchdog.com
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION